Peripheral neuropathy in metachromatic leukodystrophy: current status and future perspective

S Beerepoot, S Nierkens, JJ Boelens… - Orphanet journal of rare …, 2019 - Springer
Metachromatic leukodystrophy (MLD) is an autosomal recessively inherited metabolic
disease characterized by deficient activity of the lysosomal enzyme arylsulfatase A. Its …

Metachromatic leukodystrophy: To screen or not to screen?

AI Jonckheere, SDK Kingma, F Eyskens… - European Journal of …, 2023 - Elsevier
Metachromatic leukodystrophy (MLD) is a neurodegenerative lysosomal storage disorder
caused by biallelic pathogenic variants in the gene encoding arylsulfatase A. Disease onset …

Deep mutational scanning reveals a correlation between degradation and toxicity of thousands of aspartoacylase variants

M Grønbæk-Thygesen, V Voutsinos… - Nature …, 2024 - nature.com
Unstable proteins are prone to form non-native interactions with other proteins and thereby
may become toxic. To mitigate this, destabilized proteins are targeted by the protein quality …

Comparative efficacy and safety of multiple routes of direct CNS administration of adeno-associated virus gene transfer vector serotype rh. 10 expressing the human …

JB Rosenberg, D Sondhi, DG Rubin… - Human gene therapy …, 2014 - liebertpub.com
Metachromatic leukodystrophy (MLD), a fatal disorder caused by deficiency of the lysosomal
enzyme arylsulfatase A (ARSA), is associated with an accumulation of sulfatides, causing …

Cellular and molecular mechanisms of aspartoacylase and its role in Canavan disease

M Grønbæk-Thygesen, R Hartmann-Petersen - Cell & Bioscience, 2024 - Springer
Canavan disease is an autosomal recessive and lethal neurological disorder, characterized
by the spongy degeneration of the white matter in the brain. The disease is caused by a …

Outcome of early juvenile onset metachromatic leukodystrophy after unrelated cord blood transplantation: a case series and review of the literature

X Chen, D Gill, P Shaw, R Ouvrier… - Journal of Child …, 2016 - journals.sagepub.com
The purpose of this study was to determine whether transplantation of umbilical cord blood
from unrelated donors before the development of symptoms could halt the progression of …

Non-genetic therapeutic approaches to Canavan disease

RB Roscoe, C Elliott, A Zarros, GS Baillie - Journal of the neurological …, 2016 - Elsevier
Canavan disease (CD) is a rare leukodystrophy characterized by diffuse spongiform white
matter degeneration, dysmyelination and intramyelinic oedema with consequent impairment …

Brain abnormalities in fucosidosis: transplantation or supportive therapy?

M Jiang, S Liu, H Jiang, Y Lin, Y Shao, H Hu… - Metabolic brain …, 2017 - Springer
Fucosidosis is a rare lysosomal storage disease caused by α-fucosidase deficiency, which
leads to progressive neurological deterioration and death. Hematopoietic stem cell …

[HTML][HTML] Newborn screening in metachromatic leukodystrophy–European consensus-based recommendations on clinical management

L Laugwitz, DH Schoenmakers, LA Adang… - European journal of …, 2024 - Elsevier
Introduction Metachromatic leukodystrophy (MLD) is a rare autosomal recessive lysosomal
storage disorder resulting from arylsulfatase A enzyme deficiency, leading to toxic sulfatide …

Combined therapies for lysosomal storage diseases

J Jakobkiewicz-Banecka, M Malinowska… - Current Molecular …, 2015 - ingentaconnect.com
Lysosomal storage diseases (LSDs) is a group consisting of over 50 disorders caused
mostly by dysfunctions of lysosomal proteins and resultant accumulation of particular …